“Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST studyGuy Brusselle, Ivo Abraham, Charles Pilette et al.|Respiratory Medicine|2009Cited by 198
Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol)Jolien Onsea, Willem‐Jan Metsemakers, Saartje Uyttebroek et al.|Viruses|2021Cited by 50
Optimization of bacteriophage therapy for difficult-to-treat musculoskeletal infections: a bench-to-bedside perspectiveLaura Bessems, Jolien Onsea, Baixing Chen et al.|Frontiers in Cellular and Infection Microbiology|2024Cited by 4